11,28,000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has allotted 11,28,000 equity shares (face value ₹10 each) following the conversion of an equivalent number of fully paid convertible warrants, originally issued via preferential allotment on August 6, 2025 at ₹42.25 per warrant. The company received the balance 75% exercise price of ₹31.6875 per share, totalling ₹3.57 crore. As a result, paid-up equity capital rose from ₹12.87 crore (1.28 crore shares) to ₹14.00 crore (1.40 crore shares). The allottees include 2 promoter group members and 3 non-promoter individuals, with no remaining warrants outstanding from this tranche.
This is a routine warrant-to-equity conversion that increases the share count by about 8.8%, leading to mild dilution for existing shareholders. No fresh capital beyond what was already committed is being raised, so the immediate impact on stock price is expected to be limited.